(Q83969769)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16767370%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Histological complete response in advanced gastric cancer after 2 weeks of S-1 administration as neoadjuvant chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16767370%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16767370%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Shusuke Mori

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16767370%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Hirofumi Kishimoto

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16767370%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Katsunori Tauchi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16767370%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16767370%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16767370%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16767370%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16767370%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

136-139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16767370%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10120-005-0358-z

29 January 2020

exact match

0 references

cites work

Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer

1 reference

12 December 2020

Clinical implications of dihydropyrimidine dehydrogenase inhibition.

1 reference

12 December 2020

Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: report of a case

1 reference

12 December 2020

Current topics of S-1 at the 74th Japanese Gastric Cancer Congress

1 reference

12 December 2020

Japanese classification of gastric carcinoma--2nd English edition--response assessment of chemotherapy and radiotherapy for gastric carcinoma: clinical criteria

1 reference

12 December 2020

Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators

1 reference

12 December 2020

A case report of advanced cardiac cancer showing a complete response to TS-1 as neoadjuvant chemotherapy

1 reference

12 December 2020

Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines

1 reference

12 December 2020

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

1 reference

12 December 2020

Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group

1 reference

12 December 2020

A case of advanced gastric cancer responding to neoadjuvant TS-1/CDDP therapy

1 reference

12 December 2020

Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients

1 reference

12 December 2020

Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey

1 reference

12 December 2020

A new regimen for S-1 therapy aiming at adverse reaction mitigation and prolonged medication by introducing a 1-week drug-free interval after each 2-week dosing session: efficacy and feasibility in clinical practice

1 reference

12 December 2020

Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues

1 reference

12 December 2020